Higher Risk of Hypoglycemia with Glimepiride Versus Vildagliptin in Patients with Type 2 Diabetes is not Driven by High Doses of Glimepiride: Divergent Patient Susceptibilities?
Crossref DOI link: https://doi.org/10.1007/s13300-014-0082-y
Published Online: 2014-09-18
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ahrén, Bo
Foley, James Edward
Dejager, Sylvie
Akacha, Mouna
Shao, Qing
Heimann, Guenter
Dworak, Markus
Schweizer, Anja
Text and Data Mining valid from 2014-09-18
Article History
Received: 28 July 2014
First Online: 18 September 2014